My watch list  

Founded in 2017, Heidelberg Delivery Technologies GmbH (HEIDELTEC), offers a novel liposomal matrix system that enables the oral administration of peptide and protein drugs in a solid form, without the need for syringes.

The Heidelberg-based company is a spin-off from the pharmaceutical technology of the Ruprecht-Karls-University of Heidelberg, and is part of the EXIST research transfer program funded by the German Federal Ministry of Economics and Energy.

With its PEPTORAL® technology, HEIDELTEC services clients and licensees from the pharmaceutical industry and the life science sector. By offering them the opportunity to reformulate or newly formulate peptide and protein active ingredients for oral administration. The PEPTORAL® technology uses an innovative, patent-pending, liposomal matrix formulation, which safely encapsulates the active substance during its passage through the stomach, and ensures intestinal absorption into the blood. It offers high storage stability and allows a controlled single dose of the active ingredients.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE